Inspire Medical Systems Net Change in Property, Plant, and Equipment 2017-2025 | INSP
Inspire Medical Systems net change in property, plant, and equipment from 2017 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
| Inspire Medical Systems Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $-39 |
| 2023 | $-24 |
| 2022 | $-9 |
| 2021 | $-5 |
| 2020 | $-2 |
| 2019 | $-3 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.426B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.174B | 54.11 |
| Hims & Hers Health (HIMS) | United States | $13.701B | 142.35 |
| Tempus AI (TEM) | United States | $10.751B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.508B | 0.00 |
| Privia Health (PRVA) | United States | $2.989B | 204.33 |
| Enovis (ENOV) | United States | $1.969B | 10.98 |
| Clover Health Investments (CLOV) | United States | $1.878B | 0.00 |
| Schrodinger (SDGR) | United States | $1.573B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.348B | 23.78 |
| Azenta (AZTA) | United States | $1.294B | 60.15 |
| 10x Genomics (TXG) | United States | $1.118B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 150.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.472B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 830.67 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.192B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |